Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by RASHMI KRISHNA MURTHY and RACHEL M. LAYMAN.
RASHMI KRISHNA MURTHY
Connection Strength
0.098
RACHEL M. LAYMAN
  1. A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer. Breast Cancer Res Treat. 2023 Jun; 199(3):457-469.
    View in: PubMed
    Score: 0.055
  2. SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer. NPJ Breast Cancer. 2019; 5:16.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.